Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the short and long term safety and effectiveness of
ustekinumab in subjects with moderate to severe chronic palmar plantar psoriasis.